Managing Healthcare Costs with HRAs and GLP-1 Medications
Explore how U.S. employers use HRAs for GLP-1 drugs to control costs, enhance flexibility, and improve employee benefits amidst rising healthcare expenses.
New Medicare GLP-1 Coverage Options Launching July 1
Starting July 1, Medicare Part D beneficiaries can access new GLP-1 drug coverage options, revolutionizing obesity treatment and policy enforcement.
CMS Revisits GLP-1 Drug Coverage for Obesity in Medicare, Medicaid Pilot
CMS is considering a pilot program to cover GLP-1 drugs for obesity under Medicare and Medicaid, reversing earlier policy. This evolving coverage changes obesity drug access for patients and payers.